The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound.
            (Q40734041)
        
    
                
                
scientific article
            
    scientific article
                    Language:
                    
                    
                
            
            
                Current Data About 
    
        
            
    The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound.
        
    
            
        
        
            
                other details
            
        
        | description | scientific article | 
External Links
| (P356) | 10.1084/JEM.20011783 | 
| (P698) | 11994426 | 
| (P932) | 2193707 | 
| (P5875) | 11376950 | 
| (P8608) | release_mg5pvxuasjextfqxr2ufap47se |